Rotator Cuff Tears, Weight and Diabetes: Symptoms, Repair Risks and Evidence

A rotator cuff tear is a tear in one or more of the four tendons that hold the top of the upper arm bone in the shoulder socket and help lift and rotate the arm. Most tears in adults come with age, and many cause no symptoms at all ^[1]. Body weight and blood sugar matter in two places: obesity and diabetes are linked to a higher chance of having a tear ^[2][3], and, more strongly, to a higher chance that a surgical repair fails. In a 2023 meta-analysis, people with obesity had about 2.6 times the odds of a retear ^[5]. This review covers the symptoms, those risk factors, how treatment choices compare, and what is and is not known about weight loss and GLP-1 drugs.

The honest summary

• Tears are common and often silent. In a Japanese village screening, 20.7% of shoulders had a full-thickness tear, including 16.9% of people with no shoulder symptoms ^[1].
• Obesity and diabetes are linked to more tears. Obesity carried about 2.4 times the odds of a tear in a 2020 review ^[2], and diabetes about 1.3 times in a 2023 meta-analysis ^[3].
• The bigger effect is on repairs. Obesity was linked to 2.6 times the odds of retear and more complications after repair ^[5]; BMI and diabetes are both on the list of retear risk factors ^[4].
• Blood sugar control looks like it matters. In people with diabetes, better control was linked to markedly lower retear rates ^[6].
• Small, non-traumatic tears often do as well with physiotherapy. A randomized trial in people over 55 found no difference from surgery after six years ^[7].
• No trial has tested weight loss as a treatment. GLP-1 database studies conflict: some link the drugs to fewer retears after repair ^[12], others to more tears ^[11] or to no difference ^[13].

Rotator cuff tear symptoms

In the Japanese population study, shoulders with a tear more often had pain when the arm was raised into a pinching position (a positive impingement sign), less ability to lift the arm forward, and weaker strength when lifting the arm out to the side or rotating it outward ^[1].

Symptoms and tears do not line up neatly. Among people in that study with current shoulder symptoms, only 36% had a tear, while 16.9% of people with no symptoms had one ^[1]. A tear on a scan is therefore not always the cause of pain, and a painful shoulder is not always torn. Shoulder stiffness, where the arm cannot be moved even with help, is more typical of frozen shoulder, which is covered in frozen shoulder, diabetes and GLP-1 drugs.

Who gets rotator cuff tears?

Age is the dominant factor. In the screening study of 683 people (average age 58), the rate of tears rose steadily with age, and the independent risk factors were age, a history of trauma and the dominant arm ^[1]. Heavy manual work was also more common among people with tears. Body weight was not among the independent risk factors that study identified, a reminder that the weight link seen in larger analyses sits alongside a much stronger effect of age.

Obesity

A 2020 systematic review of 22 observational studies covering almost 50,000 people found that obesity (BMI 30 or above) was associated with a 25% higher odds of rotator cuff tendon problems (OR 1.25) and more than double the odds of a rotator cuff tear (OR 2.35) ^[2]. Tears serious enough to need surgery were more common in people with obesity, with odds ratios of 3.13 in men and 3.51 in women. The authors pointed to two plausible routes, low-grade inflammation and higher mechanical demand, and cautioned that the studies were observational and varied widely.

Diabetes, cholesterol and blood pressure

A 2023 meta-analysis pooled the evidence on metabolic conditions ^[3]. Diabetes was linked to rotator cuff disease overall (OR 1.49) and to tears specifically (OR 1.28). High cholesterol carried a similar association (OR 1.48), and high blood pressure a smaller one (OR 1.40). The reviewers suggested reduced blood supply to the tendon as a likely mechanism, and judged the evidence plausible for diabetes and high cholesterol but more likely affected by bias for blood pressure. They also noted a lack of studies tracking how long people had had each condition.

Weight, diabetes and rotator cuff repair

Repairs do not always hold. A 2021 meta-analysis of 14 studies and 5,693 patients reported retear rates after arthroscopic repair ranging from 10% to 94% across studies, and identified BMI and diabetes among the risk factors, alongside age, tear size, retraction, muscle fat infiltration, bone density and symptom duration ^[4].

A 2023 meta-analysis focused on obesity, pooling 13 studies and 85,497 patients ^[5]. Compared with people without obesity, those with obesity had higher odds of retear (OR 2.58), reoperation (OR 1.31) and complications (OR 1.57), slightly more pain afterward (0.73 points on a 10-point scale) and slightly lower shoulder function scores (3.6 points on a 100-point scale). Range of motion and operating time did not differ. In the 2020 review, complications after rotator cuff surgery occurred in 13.3% of people with obesity versus 8.1% without ^[2].

Blood sugar control appears to matter as much as the diagnosis of diabetes. A 2025 meta-analysis of people with diabetes having arthroscopic repair found that lower HbA1c was associated with markedly lower odds of retear (OR 0.24), based on four studies with 253 patients ^[6]. Revision surgery rates did not differ by glucose control. The evidence is small and observational, but it is consistent with the advice to bring blood sugar under control before an elective repair.

Treatment: surgery or physiotherapy?

For small tears that did not come from an injury, physiotherapy is a reasonable first step. A Finnish randomized trial assigned 180 shoulders of people over 55 with small, non-traumatic supraspinatus tears to physiotherapy alone, physiotherapy plus bone-shaving surgery (acromioplasty), or those two plus tendon repair ^[7]. After an average of 6.2 years, the improvement in shoulder function score was similar in all three groups (18.5, 17.9 and 20.0 points), as were pain and satisfaction. Eight shoulders in the physiotherapy-only group later crossed over to repair. The authors concluded that conservative treatment is a reasonable first option for this kind of tear.

That trial does not apply to every tear. Large tears, tears from a fall or other injury, and tears in younger, active people were outside its scope, so its results should not be stretched to cover them.

Does losing weight help a rotator cuff tear?

No trial has tested it. The best long-term data on weight loss and musculoskeletal pain come from the Swedish Obese Subjects study, which followed about 2,000 people after bariatric surgery and 2,000 matched controls for up to 20 years ^[8]. Surgery was linked to better recovery from pain mainly in the weight-bearing joints: knees and ankles over the long term, and back and hips in the short term. Neck and shoulder pain was tracked but was not among the regions where the abstract reports better recovery.

Weight-loss surgery is not a free pass for the shoulder either. In a small 2026 cohort, 34 people who had previously had bariatric surgery and then a rotator cuff repair had a failure rate of 20.6%, compared with 6.9% in 102 matched patients without bariatric surgery, along with more pain and lower function scores ^[9]. The authors raised nutritional deficiencies after bariatric surgery as a possible reason. The study was small and cannot prove cause.

The honest position is that weight loss improves diabetes and other conditions linked to rotator cuff problems, and lower body weight is associated with better repair outcomes, but no study shows that losing weight heals a tear or prevents a retear. The bariatric findings are one reason to keep protein and overall nutrition adequate while losing weight; see protecting muscle on a GLP-1.

What is known about GLP-1 drugs

All of the human evidence comes from large health-record databases, and it points in different directions.

• Possibly more tears. A five-year TriNetX study matched GLP-1 users with non-users and found more atraumatic rotator cuff tears among users in every group studied, along with more frozen shoulder and shoulder arthritis ^[11]. In people with type 2 diabetes starting a new drug, SGLT2 inhibitor users had a lower risk of a tear than GLP-1 users (HR 0.81), and of repair surgery (HR 0.90) ^[10].
• Possibly fewer retears. Among people with type 2 diabetes having arthroscopic repair, semaglutide users had a 2-year retear rate of 12.5% versus 18.3% in matched non-users, and far fewer complications within 90 days (11.0% versus 27.4%) ^[12].
• Possibly no difference. A 2026 study of people with type 2 diabetes compared new GLP-1 users with users of other diabetes drugs and found similar 2-year revision rates (1.0% versus 1.1%) and retear-related events (7.3% versus 8.6%) ^[13].

These studies cannot settle cause and effect. They rely on billing and diagnosis codes, the drug was not assigned at random, and people prescribed a GLP-1 may differ from those who are not in ways that matching cannot capture. A difference as large as the one in the semaglutide study, which extended to unrelated problems such as urinary infections and pneumonia, suggests the users may have been healthier to begin with ^[12]. The comparison with SGLT2 inhibitors shows a difference between two drug classes, not that GLP-1 drugs cause tears ^[10]. No randomized trial has looked at GLP-1 drugs and the rotator cuff. For the broader picture of joint complaints on these drugs, see Ozempic joint and muscle pain.

Practical guidance

• Get weakness checked. Difficulty lifting or rotating the arm outward is more suggestive of a tear than pain alone ^[1].
• Do not assume a scan explains everything. Many tears cause no symptoms ^[1].
• For a small tear without an injury, physiotherapy is a reasonable start, especially over 55 ^[7].
• Before an elective repair, work on blood sugar. Better HbA1c is linked to fewer retears ^[6].
• Treat weight loss as risk reduction, not a cure. It addresses risk factors linked to tears and repair failure, but it has not been tested as a treatment.
• Tell your surgeon about GLP-1 use and any past bariatric surgery, so anesthesia and nutrition can be planned ^[9].